HealthEquity (HQY) Tops Q4 EPS by 2c, Offers Guidance

HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $233.8 million versus the consensus estimate of $230.51 million.

GUIDANCE:

HealthEquity sees FY2024 EPS of $1.74-$1.87, versus the consensus of $1.76. HealthEquity sees FY2024 revenue of $960-975 million, versus the consensus of $961 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ennis (EBF) Reports In-Line Q1 EPS
• MP Materials seen largely insulated after China export-control move